Corcept Therapeutics Inc. CORT
$116.10
-2.03%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-28 | View → |
| 8-K | 8-K | 2026-09-23 | View → |
| 4 | 4 | 2026-09-18 | View → |
| 4 | 4 | 2026-09-18 | View → |
| 4 | 4 | 2026-09-16 | View → |
| 4 | 4 | 2026-09-16 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 4 | 4 | 2026-09-03 | View → |
| 4 | 4 | 2026-08-28 | View → |
| 4 | 4 | 2026-08-27 | View → |
| 4 | 4 | 2026-08-20 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-14 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-06 | View → |
| 4 | 4 | 2026-08-05 | View → |
| 4 | 4 | 2026-08-05 | View → |
| 4 | 4 | 2026-08-03 | View → |
| 10-Q | 10-Q | 2026-07-29 | View → |
| 8-K | 8-K | 2026-07-29 | View → |
| 4 | 4 | 2026-07-17 | View → |
| 4 | 4 | 2026-07-17 | View → |
| 4 | 4 | 2026-07-08 | View → |
| 4 | 4 | 2026-07-08 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 8-K | 8-K | 2026-06-17 | View → |
| 4 | 4 | 2026-06-17 | View → |
| 4 | 4 | 2026-06-04 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $116.10
- Market Cap
- $12.55 billion
- 52-Week Range
- $28.66 – $126.38
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.